242 related articles for article (PubMed ID: 1903340)
21. In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
Pfaller M; Bale M; Preston T; Howard W; Koontz F
Diagn Microbiol Infect Dis; 1986 May; 5(1):17-23. PubMed ID: 3086026
[TBL] [Abstract][Full Text] [Related]
22. The integration of four major determinants of antibiotic action: bactericidal activity, postantibiotic effect, susceptibility, and pharmacokinetics.
Li RC; Zhu ZY
J Chemother; 2002 Dec; 14(6):579-83. PubMed ID: 12583549
[TBL] [Abstract][Full Text] [Related]
23. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
[No Abstract] [Full Text] [Related]
24. Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.
Baltch AL; Smith RP; Ritz W
Chemotherapy; 1994; 40(6):391-8. PubMed ID: 7842822
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan.
Liu JY; Wang FD; Ho MW; Lee CH; Liu JW; Wang JT; Sheng WH; Hseuh PR; Chang SC
J Microbiol Immunol Infect; 2016 Dec; 49(6):918-923. PubMed ID: 26364729
[TBL] [Abstract][Full Text] [Related]
26. [Pharmacodynamic parameters of gentamicin and its effect on the surface hydrophobicity of Acinetobacter baumannii].
Hostacká A
Ceska Slov Farm; 2000 Jan; 49(1):41-4. PubMed ID: 10953442
[TBL] [Abstract][Full Text] [Related]
27. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
[TBL] [Abstract][Full Text] [Related]
28. Postantibiotic effect of aminoglycosides on gram-negative bacteria evaluated by a new method.
Isaksson B; Nilsson L; Maller R; Sörén L
J Antimicrob Chemother; 1988 Jul; 22(1):23-33. PubMed ID: 3139614
[TBL] [Abstract][Full Text] [Related]
29. [The combined effects of aspoxicillin with aminoglycoside antibiotics on Pseudomonas aeruginosa].
Matsushita T; Kasuga O; Yamaguchi T
Jpn J Antibiot; 1990 Apr; 43(4):677-85. PubMed ID: 2116537
[TBL] [Abstract][Full Text] [Related]
30. Postantibiotic effect of a combination of antimicrobial agents on pseudomonas aeruginosa.
Sood P; Mandal A; Mishra B
Chemotherapy; 2000; 46(3):173-6. PubMed ID: 10765031
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial susceptibility of gentamicin-resistant Pseudomonas aeruginosa.
Yu PK; Washington JA
Mayo Clin Proc; 1977 Dec; 52(12):802-5. PubMed ID: 413013
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Pseudomonas aeruginosa alginate expression by subinhibitory concentrations of antibiotics.
Majtán V; Hybenová D
Folia Microbiol (Praha); 1996; 41(1):61-4. PubMed ID: 9090826
[TBL] [Abstract][Full Text] [Related]
33. Antibiotic exposure and its relationship to postantibiotic effect and bactericidal activity: constant versus exponentially decreasing tobramycin concentrations against Pseudomonas aeruginosa.
Li RC; Zhu ZY; Lee SW; Raymond K; Ling JM; Cheng AF
Antimicrob Agents Chemother; 1997 Aug; 41(8):1808-11. PubMed ID: 9257767
[TBL] [Abstract][Full Text] [Related]
34. Invitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Kang AD; Smith KP; Eliopoulos GM; Berg AH; McCoy C; Kirby JE
Diagn Microbiol Infect Dis; 2017 Jun; 88(2):188-191. PubMed ID: 28341099
[TBL] [Abstract][Full Text] [Related]
35. Optimization of Synergistic Combination Regimens against Carbapenem- and Aminoglycoside-Resistant Clinical Pseudomonas aeruginosa Isolates via Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling.
Yadav R; Bulitta JB; Nation RL; Landersdorfer CB
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821448
[TBL] [Abstract][Full Text] [Related]
36. Incorporation, release and in-vitro antibacterial activity of liposomal aminoglycosides against Pseudomonas aeruginosa.
Omri A; Ravaoarinoro M; Poisson M
J Antimicrob Chemother; 1995 Oct; 36(4):631-9. PubMed ID: 8591937
[TBL] [Abstract][Full Text] [Related]
37. Preclinical comparative evaluation of aminoglycosides.
Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
[TBL] [Abstract][Full Text] [Related]
38. [Comparative study of the sensitivity of Enterobacteriaceae and Pseudomonas aeruginosa with 4 aminoglycosides].
Turgeon P; Lamothe F; Vincelette J; Gaudreau C; Bourgault AM; Turgeon F
Union Med Can; 1984 Jun; 113(6):522-4. PubMed ID: 6435299
[No Abstract] [Full Text] [Related]
39. Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli with a cation-supplemented inoculum.
Cherne JE; Peterson LR
Antimicrob Agents Chemother; 1980 Jul; 18(1):210-1. PubMed ID: 6774664
[TBL] [Abstract][Full Text] [Related]
40. Global and effective synergism of amikacin, gentamicin or tobramycin when combined with carbenicillin against Pseudomonas aeruginosa.
Ximenes J; Hirai CK; Takenaka IM
J Int Med Res; 1979; 7(5):375-8. PubMed ID: 115732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
